Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;

NAFLD: Challenges and opportunities to address the public health challenge in Latin America Juan Pablo Arab; Luis Antonio Díaz; Melisa Dirchwolf; Henry Mark; Jeffrey V. Lazarus; Elly Vaughan; Nahum Méndez-Sánchez; Claudia P. de Oliveira; Adrián Gadano; Marco Arrese;

Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease Hao Ding; Ge Ge; Yujen Tseng; Yanyun Ma; Jun Zhang; Jie Liu;